Amoy Diagnostics Co., Ltd. (300685.SZ)
CNY 21.0
(-0.43%)
CNY 21.0
(-0.43%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 44.4 Million CNY | -8.08% |
| 2022 | 48.3 Million CNY | 1507.71% |
| 2021 | 3 Million CNY | 20.3% |
| 2020 | 2.49 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | -100.0% |
| 2014 | 18.14 Million CNY | 64.88% |
| 2013 | 11 Million CNY | 6193.18% |
| 2012 | 174.85 Thousand CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | - CNY | 0.0% |
| 2024 Q2 | 3.74 Million CNY | -100.0% |
| 2024 Q1 | 43.78 Million CNY | -1.4% |
| 2023 Q3 | 47.59 Million CNY | 2.2% |
| 2023 Q4 | 44.4 Million CNY | -6.72% |
| 2023 FY | 44.4 Million CNY | -8.08% |
| 2023 Q1 | 48.37 Million CNY | 0.15% |
| 2023 Q2 | 46.57 Million CNY | -3.72% |
| 2022 Q4 | 48.3 Million CNY | -11.02% |
| 2022 Q1 | 2.82 Million CNY | -5.9% |
| 2022 Q2 | 54.05 Million CNY | 1811.95% |
| 2022 FY | 48.3 Million CNY | 1507.71% |
| 2022 Q3 | 54.28 Million CNY | 0.42% |
| 2021 Q3 | 3.05 Million CNY | -10.45% |
| 2021 FY | 3 Million CNY | 20.3% |
| 2021 Q1 | - CNY | 0.0% |
| 2021 Q2 | 3.41 Million CNY | 0.0% |
| 2021 Q4 | 3 Million CNY | -1.63% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 FY | 2.49 Million CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 FY | - CNY | -100.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2014 FY | 18.14 Million CNY | 64.88% |
| 2013 FY | 11 Million CNY | 6193.18% |
| 2012 FY | 174.85 Thousand CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 2.33 Billion CNY | 98.095% |
| Hangzhou Tigermed Consulting Co., Ltd. | 434.22 Million CNY | 89.775% |
| Dirui Industrial Co.,Ltd. | 3.66 Million CNY | -1110.797% |
| Beijing Strong Biotechnologies, Inc. | 1.13 Billion CNY | 96.077% |
| Medicalsystem Biotechnology Co., Ltd. | 23.59 Million CNY | -88.168% |
| Maccura Biotechnology Co.Ltd | 175.47 Million CNY | 74.698% |
| Guangzhou Wondfo Biotech Co.,Ltd | 580.52 Million CNY | 92.352% |
| Guangdong Hybribio Biotech Co.,Ltd. | 28.26 Million CNY | -57.065% |
| BGI Genomics Co., Ltd. | 283.42 Million CNY | 84.335% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 166.83 Million CNY | 73.387% |